These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2026488)

  • 1. Phase II clinical trial of 4'-O-tetrahydropyranyl-adriamycin (THP-adriamycin) in recurrent squamous cell carcinoma of the head and neck.
    Shin DM; Kramer AM; Dimery IW; Raber MN; Ewer M; Hong WK
    Invest New Drugs; 1991 Feb; 9(1):89-91. PubMed ID: 2026488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of esorubicin (4'-deoxydoxorubicin) in locally advanced or metastatic head and neck carcinoma.
    Frustaci S; Gasparini G; Veronesi A; Tirelli U; Pacciarini MA; Crivellari D; Zagonel V; Monfardini S
    Invest New Drugs; 1987; 5(3):307-9. PubMed ID: 3667167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of Adriamycin in previously untreated squamous cell carcinoma of the head and neck.
    Cobleigh MA; Hill JH; Gallagher PA; Kukla LJ; Lad TE; Shevrin DH; Applebaum EL; McGuire WP
    Cancer; 1985 Dec; 56(11):2573-5. PubMed ID: 4052934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of pirarubicin in patients with advanced recurrent head and neck squamous cell carcinoma.
    De Mulder PH; Cappelaere P; Cognetti F; Verweij J; Schornagel JH; Vermorken JB; Kirkpatrick A; Lefebvre JL
    Cancer Chemother Pharmacol; 1994; 33(5):438-40. PubMed ID: 8306420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology and toxicity of 4'-O-tetrahydropyranyladriamycin.
    Miller AA; Schmidt CG
    Cancer Res; 1987 Mar; 47(5):1461-5. PubMed ID: 3815348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of 4'-0-tetrahydropyranyladriamycin (pirarubicin) in head and neck carcinoma.
    Sridhar KS; Hussein AM; Benedetto P; Ardalan B; Savaraj N; Richman SP
    Cancer; 1992 Sep; 70(6):1591-7. PubMed ID: 1516010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
    Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
    Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
    J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraarterial infusion of 4'-O-tetrahydropyranyl-adriamycin for head and neck tumors.
    Honda T; Ohyama W; Sonoda T; Uchida K; Hirokawa T; Takada K; Takeda C
    Jpn J Antibiot; 1984 Jun; 37(6):959-65. PubMed ID: 6492386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multi-institutional cooperative study on combination chemotherapy with THP, CDDP and 5-FU for squamous cell carcinoma of the head and neck].
    Urade M; Yanagisawa T; Kishimoto H; Yoshioka W; Teranobu O; Shigeta Y; Komori T; Shimada K; Ohnishi M; Tanaka Y; Kamiya Y; Akazawa N; Oko T; Takahashi N; Adachi R; Tanigaki S; Hirata Y; Yakushiji N; Kitamura R; Hashikawa N;
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):789-95. PubMed ID: 11432346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I-II trial of induction chemotherapy with carboplatin and fluorouracil in locally advanced head and neck squamous cell carcinoma: a report from the UCL-Oncology Group, Belgium.
    Grégoire V; Beauduin M; Humblet Y; Hamoir M; Longueville J; Majois F; Remacle FM; Rousseau F; Salamon E; Wambersie A
    J Clin Oncol; 1991 Aug; 9(8):1385-92. PubMed ID: 2072142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical phase II evaluation of paclitaxel in combination with cisplatin in metastatic or recurrent squamous cell carcinoma of the head and neck.
    Thödtmann F; Theiss F; Kemmerich M; Heinrich B; Laubenbacher C; Quasthoff S; Kau R; Herzog M; Diergarten K; Hanauske AR
    Ann Oncol; 1998 Mar; 9(3):335-7. PubMed ID: 9602270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II trial of cyclophosphamide and adriamycin in refractory squamous cell carcinoma of the head and neck. An effective salvage regimen.
    Bitran JD; Goldman M
    Am J Clin Oncol; 1985 Feb; 8(1):61-4. PubMed ID: 2581437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK
    Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locoregional effects of pegylated liposomal doxorubicin (Caelyx) in irradiated area: a phase I-II study in patients with recurrent squamous cell carcinoma of the head and neck.
    Faivre S; Alsabe H; Djafari L; Janot F; Julieron M; Domenge C; Djazouli K; Armand JP; Luboinski B; Raymond E
    Eur J Cancer; 2004 Jul; 40(10):1517-21. PubMed ID: 15196535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced or metastatic squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.
    McGuire WP; Blessing JA; Yordan E; Beecham J
    Invest New Drugs; 1989 Jul; 7(2-3):235-8. PubMed ID: 2793379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin alone or in combination with adriamycin in the treatment of patients with head and neck cancer relapsed after radiotherapy and/or surgery.
    Villar A; Farrus B; Giner P; Sedano E; Serradell J; de Caralt M
    Rev Esp Oncol; 1981; 28(3):395-412. PubMed ID: 6892263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of bolus tetrahydropyranyl adriamycin and 120 hours continuous 5-fluorouracil infusion in patients with metastatic breast cancer.
    Chevallier B; Fumoleau P; Kerbrat P; Monnier A; Roche H; Goudie MJ; Herait P
    Am J Clin Oncol; 1990; 13 Suppl 1():S40-3. PubMed ID: 2291456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: a preliminary report.
    Hussain M; Salwen W; Kucuk O; Ensley J
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-43-S19-45. PubMed ID: 9427265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.
    Mantovani G; Ghiani M; Lai P; Maccio A; Dessi D; Succu G; Massa D; Curreli L; Mulas C; Esu S; Proto E; Cadeddu G; Tore G
    Oncol Rep; 1998; 5(6):1499-505. PubMed ID: 9769395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.